Related Experiment Video

Updated: May 14, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Markers of cardiotoxicity in breast cancer patients

Marielle Scherrer-Crosbie

    Clinical Advances in Hematology & Oncology : H&O
    |February 19, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: May 14, 2026

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
    05:14

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

    Published on: May 16, 2020

    Related Concept Videos

    Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

    Blood Studies for Cardiovascular System I: Cardiac Biomarkers

    Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
    The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
    Troponins
    Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

    Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
    These markers indicate stress or strain on the heart muscle:
    Natriuretic Peptides (BNP)
    Cardiac myocytes produce these hormones in response to ventricular stretching...

    Articles linked to this work by shared authors, journal, and citation graph.

    Cardiovascular risk-prediction models in cancer survivors: a meta-analysis.

    European heart journal·2026

    Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

    Circulation·2026

    Utilization of Guideline-Directed Medical Therapies and Transcatheter-Edge-to-Edge Repair in Patients with Significant Secondary Mitral Regurgitation.

    Cardiology·2026

    Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort Study.

    JACC. Advances·2026

    Multimodal Artificial Intelligence for Cardiac Amyloidosis Diagnosis: Integrating Echocardiography With Clinical and Laboratory Data for Improved Detection.

    Circulation. Cardiovascular imaging·2026

    Cardiovascular Adverse Events During Venetoclax-Based Treatment in Acute Myeloid Leukemia.

    Journal of the American Heart Association·2026

    Redefining second-line treatment strategy, sequencing, and real-world implementation in relapsed/refractory multiple myeloma: insights from the 31st Annual Congress of the European Hematology Association.

    Clinical advances in hematology & oncology : H&O·2026

    Neoadjuvant therapies in high-risk localized prostate cancer: past, present, and future.

    Clinical advances in hematology & oncology : H&O·2026

    Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations.

    Clinical advances in hematology & oncology : H&O·2026

    Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.

    Clinical advances in hematology & oncology : H&O·2026

    Serum small extracellular vesicle-associated snoRNA panel adds diagnostic value to CEA and CYFRA21-1 for non-small cell lung cancer: an exploratory single-center study.

    Frontiers in oncology·2026

    The value of machine learning models in predicting lung metastasis in papillary thyroid carcinoma.

    Frontiers in endocrinology·2026

    Integrated bulk-single-cell transcriptomics identifies IL17RB as a candidate prognostic marker in colon cancer.

    In silico pharmacology·2026

    Development and temporal validation of preoperative and combined preoperative-pathological models for lymph node metastasis in early gastric cancer.

    Frontiers in oncology·2026

    Other primary malignancies are associated with inferior survival in multiple myeloma: a single-center matched retrospective cohort study.

    Frontiers in oncology·2026

    Externally validated explainable machine learning for postoperative recurrence prediction in early-stage NSCLC.

    Frontiers in oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us